ABOUT US

Global Oncology One, Inc. is dedicated to the development of cancer treatment plans. The University of Texas MD Anderson Cancer Center (“MD Anderson”) is a shareholder of Global Oncology One, Inc.

 

U.S. News & World Report has ranked MD Anderson as one of the top two hospitals in the United States for cancer care since U.S. News & World Report began its survey.

 

Global Oncology One, working with well-known international cancer centers, seeks to promote its knowledge and resources, and to enlarge its cancer network throughout the world.

OUR COMPANY
  • Global Oncology One has exclusively licensed radiation treatment planning software developed at MD Anderson.

     

  • Comprised of a team of experts in oncology, physics and biology, with a network to international cancer treatment facilities

INVESTOR RELATIONS
  • The University of Texas MD Anderson Cancer Center (“MD Anderson”) is a shareholder of Global Oncology One, Inc.

WHY CHOOSE US
  • Experienced quality assurance experts and consulting committee

     

  • Services across a global platform

     

  • The most advanced radiation treatment planning technology in the world